MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,000 | -33.3% | 1,097 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 1,097 | +12.5% | 0.00% | – |
Q4 2018 | $3,000 | -25.0% | 975 | +29.8% | 0.00% | – |
Q3 2018 | $4,000 | -99.8% | 751 | +152.0% | 0.00% | – |
Q2 2018 | $1,910,000 | +190900.0% | 298 | +127.5% | 0.00% | – |
Q1 2018 | $1,000 | – | 131 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 3,142,580 | $2,451,000 | 0.41% |
Virtu Financial LLC | 112,200 | $87,000 | 0.02% |
Seelaus Asset Management LLC | 17,175 | $13,000 | 0.01% |
Aveo Capital Partners, LLC | 16,732 | $13,000 | 0.01% |
Qube Research & Technologies Ltd | 366,710 | $284,000 | 0.00% |
Banque Cantonale Vaudoise | 50,000 | $39,000 | 0.00% |
GSA CAPITAL PARTNERS LLP | 19,327 | $15,000 | 0.00% |
OneDigital Investment Advisors LLC | 11,029 | $9,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 8,898 | $7,000 | 0.00% |
NORTHERN TRUST CORP | 72,929 | $56,000 | 0.00% |